LV12498B - ANTIOAGULANT COMPOSITION - Google Patents

ANTIOAGULANT COMPOSITION Download PDF

Info

Publication number
LV12498B
LV12498B LVP-00-25A LV000025A LV12498B LV 12498 B LV12498 B LV 12498B LV 000025 A LV000025 A LV 000025A LV 12498 B LV12498 B LV 12498B
Authority
LV
Latvia
Prior art keywords
solution
blood
heparin
anticoagulant
heavy metal
Prior art date
Application number
LVP-00-25A
Other languages
English (en)
Latvian (lv)
Other versions
LV12498A (en
Inventor
Edward MANCILLA
Elizabeth Mary LAGWINSKA
Original Assignee
American Home Products Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corporation filed Critical American Home Products Corporation
Publication of LV12498A publication Critical patent/LV12498A/xx
Publication of LV12498B publication Critical patent/LV12498B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727Heparin; Heparan
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331Preservative, buffer, anticoagulant or diluent
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Soil Conditioners And Soil-Stabilizing Materials (AREA)
LVP-00-25A 1993-01-27 2000-02-23 ANTIOAGULANT COMPOSITION LV12498B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US962793A 1993-01-27 1993-01-27
US08/096,123 US5336620A (en) 1993-01-27 1993-07-22 Process for the production of an anticoagulant composition

Publications (2)

Publication Number Publication Date
LV12498A LV12498A (en) 2000-06-20
LV12498B true LV12498B (en) 2000-09-20

Family

ID=26679701

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-00-25A LV12498B (en) 1993-01-27 2000-02-23 ANTIOAGULANT COMPOSITION

Country Status (15)

Country Link
US (4) US5336620A (es)
EP (1) EP0681590B1 (es)
JP (1) JP3278661B2 (es)
KR (1) KR960700276A (es)
AT (1) ATE177434T1 (es)
AU (1) AU679498B2 (es)
CA (1) CA2154788C (es)
DE (1) DE69417017T2 (es)
DK (1) DK0681590T3 (es)
ES (1) ES2131677T3 (es)
GR (1) GR3030186T3 (es)
IL (1) IL108429A (es)
LV (1) LV12498B (es)
RU (1) RU2148376C1 (es)
WO (1) WO1994017108A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5336620A (en) * 1993-01-27 1994-08-09 American Home Products Corporation Process for the production of an anticoagulant composition
US20020055710A1 (en) 1998-04-30 2002-05-09 Ronald J. Tuch Medical device for delivering a therapeutic agent and method of preparation
US5552323A (en) * 1994-08-03 1996-09-03 Mercereau; Steven F. Method of blending an anticoagulant
US6238578B1 (en) * 1996-12-09 2001-05-29 Sherwood Services Ag Method for dispensing separator gel in a blood collection tube
WO1998029126A1 (en) * 1996-12-27 1998-07-09 Sherwood Medical Company Anticoagulant composition
AU7104498A (en) * 1997-04-08 1998-10-30 Injectimed, Inc. Method and apparatus for collecting blood
US5900291A (en) * 1997-05-19 1999-05-04 Pebbles; Patricia J. Non-light penetrating phlebotomy tube with temperature sensitive level indicator
US6106454A (en) * 1997-06-17 2000-08-22 Medtronic, Inc. Medical device for delivering localized radiation
US6203536B1 (en) * 1997-06-17 2001-03-20 Medtronic, Inc. Medical device for delivering a therapeutic substance and method therefor
US6013099A (en) 1998-04-29 2000-01-11 Medtronic, Inc. Medical device for delivering a water-insoluble therapeutic salt or substance
US6206914B1 (en) 1998-04-30 2001-03-27 Medtronic, Inc. Implantable system with drug-eluting cells for on-demand local drug delivery
US20030069601A1 (en) * 1998-12-15 2003-04-10 Closys Corporation Clotting cascade initiating apparatus and methods of use
JP2001161668A (ja) * 1999-12-07 2001-06-19 Terumo Corp 採血器具
DK1389955T3 (da) * 2001-05-10 2010-03-01 Chempaq As Indretning til at udtage prøve af små og præcise væskevolumener
US7648678B2 (en) * 2002-12-20 2010-01-19 Dako Denmark A/S Method and system for pretreatment of tissue slides
CN100335506C (zh) * 2004-05-20 2007-09-05 汕头市金丰医疗器械科技有限公司 一种肝素化合物及其制备方法和应用
CN1308351C (zh) * 2005-11-21 2007-04-04 武汉理工大学 离子平衡交换法制备肝素锂
US20090036841A1 (en) * 2007-08-01 2009-02-05 Mckale James M Coatings for blood and bone marrow-contacting devices
US11517232B1 (en) * 2014-11-07 2022-12-06 Labrador Dlagnostics LLC Systems and methods for mobile sample collection
CN109232773A (zh) * 2018-11-29 2019-01-18 淮安麦德森制药有限公司 肝素锂的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3337409A (en) * 1963-11-20 1967-08-22 Rexall Drug Chemical Process for the recovery of heparin
US3817831A (en) * 1973-01-10 1974-06-18 Wilson Pharm & Chem Corp Process for production of alkali metal salt of heparin
FR2495935A1 (fr) * 1980-12-15 1982-06-18 Choay Sa Fractions mucopolysaccharidiques possedant des proprietes biologiques, leur procede de preparation et leur application en tant que medicaments
US4521975A (en) * 1981-05-04 1985-06-11 Marquest Medical Products, Inc. Lyophilizing and forming biologicals having a predetermined unit dosage
US4479799A (en) * 1981-05-21 1984-10-30 Riker Laboratories, Inc. Hypodermic syringe containing microfibers of an amorphous heparin salt
JPS58138441A (ja) * 1982-02-15 1983-08-17 テルモ株式会社 血液採取器
DE3366540D1 (en) * 1982-04-28 1986-11-06 Trustees Of The Garfield Westo Processes for the production of blood products
DK150403C (da) * 1983-07-15 1987-07-13 Radiometer As Blodproevetagningsudstyr
CA1327354C (en) * 1987-03-19 1994-03-01 David Cullis-Hill Anti-inflamatory compounds and compositions
SE8702254D0 (sv) * 1987-05-29 1987-05-29 Kabivitrum Ab Novel heparin derivatives
IT1234826B (it) * 1989-01-30 1992-05-29 Alfa Wassermann Spa Derivati eparinici e procedimento per la loro preparazione
JP2540649B2 (ja) * 1990-04-27 1996-10-09 テルモ株式会社 採血管
US5336620A (en) * 1993-01-27 1994-08-09 American Home Products Corporation Process for the production of an anticoagulant composition

Also Published As

Publication number Publication date
GR3030186T3 (en) 1999-08-31
EP0681590A1 (en) 1995-11-15
IL108429A (en) 1998-06-15
IL108429A0 (en) 1994-04-12
US5580789A (en) 1996-12-03
US5399318A (en) 1995-03-21
WO1994017108A1 (en) 1994-08-04
EP0681590B1 (en) 1999-03-10
US6340675B1 (en) 2002-01-22
RU2148376C1 (ru) 2000-05-10
ES2131677T3 (es) 1999-08-01
ATE177434T1 (de) 1999-03-15
LV12498A (en) 2000-06-20
DE69417017D1 (de) 1999-04-15
AU679498B2 (en) 1997-07-03
DK0681590T3 (da) 1999-09-27
DE69417017T2 (de) 2001-01-11
KR960700276A (ko) 1996-01-19
AU6095894A (en) 1994-08-15
US5336620A (en) 1994-08-09
JPH08506184A (ja) 1996-07-02
CA2154788C (en) 2006-06-06
JP3278661B2 (ja) 2002-04-30
CA2154788A1 (en) 1994-08-04

Similar Documents

Publication Publication Date Title
LV12498B (en) ANTIOAGULANT COMPOSITION
DE69230243T2 (de) Enzymatische neutralisierung von heparin
RU2021304C1 (ru) Способ получения биологически активной композиции
DE68917040T2 (de) Heparinderivate und Verfahren zu deren Herstellung.
EP0442843B1 (de) Inhibitoren zur antikoagulierenden Vorbehandung von Blutproben
Schramm et al. Synthesis of cellulose by Acetobacter xylinum. 1. Micromethod for the determination of celluloses
US4075314A (en) Stannous pyrophosphate technetium-99m compositions
DE69607749T2 (de) Analoge des calcitonin aus lachs, ihre herstellung und ihre verwendung als medizin und als analytische reagentien
Higgins The use of heparin in preparing samples for blood-gas analysis.
Putri et al. Synthesis and characteristics of Chitosan from Haruan (Channa striata) fish scales
DE68912477T3 (de) Verfahren zum messen der biologischen wirkung von antithrombin iii und reagenzkit zu dessen messung
Eiber et al. Studies made with radioactive heparin in humans
EP0539839B1 (de) Stabiles flüssiges Kontroll- bzw. Eichserum für die klinische Diagnostik
EP0313712B1 (de) Stabile radiodiagnostische Präparate und ihre Herstellung
Jellum et al. Mercaptodextran, a metal-chelating and disulphide-reducing polythiol of high molecular weight
DE69619767T2 (de) Neue Verabreichungsform von Hydroxocobalamin und ihre Verwendung bei Cyanidvergiftungen
DE60212542T2 (de) Injektionslösung enthaltend ein Kolloid aus Eisen und Haiknorpel-Chondroitinsulfat
IL118881A (en) A device for collecting blood and a device for using it
EP0007911A1 (en) Zinc and/or cerium containing sulfonylurea hypoglycemic agents, preparation and use thereof
US5472950A (en) Compositions containing cobalt hyaluronic acid complex
DE2419310B2 (de) Verwendung von Tc-99m-Komplexen
DE69615991T2 (de) Verfahren und Reagenz zum Nachweis von Ionen unter Verwendung von Maltose Derivaten
EP0019790A2 (de) Technetium-99m-markierte Acetanilidoiminodiacetate zur Leberfunktionsdiagnostik und Verfahren zu ihrer Herstellung
SU947999A1 (ru) Фторированные аналоги простациклина,про вл ющие антиагрегационную активность и способ их получени
DE69621287T2 (de) Stabile flüssige Urobilinogen-Kontrollzusammensetzung